| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |